Cargando…
The clinical features of retinal disease due to a dominant mutation in RPE65
PURPOSE: To present a detailed phenotypic and molecular study of two families with autosomal dominant RPE65-related retinal dystrophy. METHODS: Five patients from two families were ascertained from the retinal clinics of a tertiary referral center. Phenotyping included retinal imaging and electrophy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901053/ https://www.ncbi.nlm.nih.gov/pubmed/27307694 |
_version_ | 1782436733929914368 |
---|---|
author | Hull, Sarah Mukherjee, Rajarshi Holder, Graham E. Moore, Anthony T. Webster, Andrew R. |
author_facet | Hull, Sarah Mukherjee, Rajarshi Holder, Graham E. Moore, Anthony T. Webster, Andrew R. |
author_sort | Hull, Sarah |
collection | PubMed |
description | PURPOSE: To present a detailed phenotypic and molecular study of two families with autosomal dominant RPE65-related retinal dystrophy. METHODS: Five patients from two families were ascertained from the retinal clinics of a tertiary referral center. Phenotyping included retinal imaging and electrophysiological testing. Bidirectional Sanger sequencing of exon 13 of RPE65 and its intron–exon boundaries was performed on all reported patients and segregation confirmed in available relatives. The main outcome measures were the results of an ophthalmic examination and investigation and molecular genetic analysis. RESULTS: Four affected patients from two families presented with nyctalopia and central visual disturbance in adulthood progressing to severe visual loss by the fifth to eighth decades. The patients had extensive chorioretinal atrophy with a relatively preserved anterior retina. In the second family, one patient had bilateral, vitelliform-like foveal lesions consistent with adult onset vitelliform macular dystrophy and no peripheral retinal changes. These unrelated families were both heterozygous for c.1430A>G (p.Asp477Gly). One unaffected family member also tested positive for this mutation but had good vision at age 80 years. CONCLUSIONS: Autosomal dominant retinal dystrophy resembling choroideremia can arise from a heterozygous mutation in RPE65. It may manifest with mild disease or be non-penetrant. Awareness of these unusual presentations can facilitate targeted molecular investigation. |
format | Online Article Text |
id | pubmed-4901053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-49010532016-06-15 The clinical features of retinal disease due to a dominant mutation in RPE65 Hull, Sarah Mukherjee, Rajarshi Holder, Graham E. Moore, Anthony T. Webster, Andrew R. Mol Vis Research Article PURPOSE: To present a detailed phenotypic and molecular study of two families with autosomal dominant RPE65-related retinal dystrophy. METHODS: Five patients from two families were ascertained from the retinal clinics of a tertiary referral center. Phenotyping included retinal imaging and electrophysiological testing. Bidirectional Sanger sequencing of exon 13 of RPE65 and its intron–exon boundaries was performed on all reported patients and segregation confirmed in available relatives. The main outcome measures were the results of an ophthalmic examination and investigation and molecular genetic analysis. RESULTS: Four affected patients from two families presented with nyctalopia and central visual disturbance in adulthood progressing to severe visual loss by the fifth to eighth decades. The patients had extensive chorioretinal atrophy with a relatively preserved anterior retina. In the second family, one patient had bilateral, vitelliform-like foveal lesions consistent with adult onset vitelliform macular dystrophy and no peripheral retinal changes. These unrelated families were both heterozygous for c.1430A>G (p.Asp477Gly). One unaffected family member also tested positive for this mutation but had good vision at age 80 years. CONCLUSIONS: Autosomal dominant retinal dystrophy resembling choroideremia can arise from a heterozygous mutation in RPE65. It may manifest with mild disease or be non-penetrant. Awareness of these unusual presentations can facilitate targeted molecular investigation. Molecular Vision 2016-06-10 /pmc/articles/PMC4901053/ /pubmed/27307694 Text en Copyright © 2016 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed. |
spellingShingle | Research Article Hull, Sarah Mukherjee, Rajarshi Holder, Graham E. Moore, Anthony T. Webster, Andrew R. The clinical features of retinal disease due to a dominant mutation in RPE65 |
title | The clinical features of retinal disease due to a dominant mutation in RPE65 |
title_full | The clinical features of retinal disease due to a dominant mutation in RPE65 |
title_fullStr | The clinical features of retinal disease due to a dominant mutation in RPE65 |
title_full_unstemmed | The clinical features of retinal disease due to a dominant mutation in RPE65 |
title_short | The clinical features of retinal disease due to a dominant mutation in RPE65 |
title_sort | clinical features of retinal disease due to a dominant mutation in rpe65 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901053/ https://www.ncbi.nlm.nih.gov/pubmed/27307694 |
work_keys_str_mv | AT hullsarah theclinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT mukherjeerajarshi theclinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT holdergrahame theclinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT mooreanthonyt theclinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT websterandrewr theclinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT hullsarah clinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT mukherjeerajarshi clinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT holdergrahame clinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT mooreanthonyt clinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 AT websterandrewr clinicalfeaturesofretinaldiseaseduetoadominantmutationinrpe65 |